Annexon, Inc. (ANNX)
3.92
-0.05
(-1.26%)
USD |
NASDAQ |
Nov 13, 16:00
3.93
+0.01
(+0.26%)
After-Hours: 19:59
Annexon Total Liabilities (Quarterly) : 107.61M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 107.61M |
| June 30, 2026 | 60.01M |
| March 31, 2026 | 58.36M |
| December 31, 2025 | 65.92M |
| September 30, 2025 | 67.70M |
| June 30, 2025 | 65.56M |
| March 31, 2025 | 59.24M |
| December 31, 2024 | 56.97M |
| September 30, 2024 | 47.22M |
| June 30, 2024 | 45.01M |
| March 31, 2024 | 41.66M |
| December 31, 2023 | 47.12M |
| September 30, 2023 | 46.98M |
| June 30, 2023 | 48.29M |
| March 31, 2023 | 53.92M |
| December 31, 2022 | 53.90M |
| Date | Value |
|---|---|
| September 30, 2022 | 52.12M |
| June 30, 2022 | 52.66M |
| March 31, 2022 | 49.96M |
| December 31, 2021 | 55.13M |
| September 30, 2021 | 45.68M |
| June 30, 2021 | 36.45M |
| March 31, 2021 | 11.64M |
| December 31, 2020 | 11.67M |
| September 30, 2020 | 10.14M |
| June 30, 2020 | 13.91M |
| March 31, 2020 | 7.673M |
| December 31, 2019 | 6.368M |
| September 30, 2019 | 150.36M |
| June 30, 2019 | 117.61M |
| March 31, 2019 | |
| December 31, 2018 | 112.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
| Arrowhead Pharmaceuticals, Inc. | 1.759B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 250.41M |
| Shareholders Equity (Quarterly) | 142.80M |
| Debt to Equity Ratio | 0.5126 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -1.13% |